Validating the portal population of the United Kingdom Multiple Sclerosis Register


      • Validation of a self declared MS Population with a clinically diagnosed one.
      • We analysed the UK MS Register for a number of key characteristics. The internet (n = 11,021) and clinical (n = 3,003) populations were studied for key shared epidemiology. We found them to be closely matched for mean age at diagnosis (clinical = 37.39, portal = 39.28) and gender ratio (female %, portal = 73.1, clinical = 75.2)
      • There is a representative population of people with MS in the online element of the UK MS Register – The MS Register can be utilised as a valid cohort for Clinical and PRO research
      • Kernel Density of the populations for age can be seen in the graphs:


      The UK Multiple Sclerosis Register (UKMSR) is a large cohort study designed to capture ‘real world’ information about living with multiple sclerosis (MS) in the UK from diverse sources. The primary source of data is directly from people with Multiple Sclerosis (pwMS) captured by longitudinal questionnaires via an internet portal. This population's diagnosis of MS is self-reported and therefore unverified. The second data source is clinical data which is captured from MS Specialist Treatment centres across the UK. This includes a clinically confirmed diagnosis of MS (by Macdonald criteria) for consented patients.
      A proportion of the internet population have also been consented at their hospital making comparisons possible. This dataset is called the ‘linked dataset’. The purpose of this paper is to examine the characteristics of the three datasets: the self-reported portal data, clinical data and linked data, in order to assess the validity of the self-reported portal data.
      The internet (n = 11,021) and clinical (n = 3,003) populations were studied for key shared characteristics. We found them to be closely matched for mean age at diagnosis (clinical = 37.39, portal = 39.28) and gender ratio (female %, portal = 73.1, clinical = 75.2). The Two Sample Kolmogorov-Smirnov test was for the continuous variables to examine is they were drawn from the same distribution. The null hypothesis was rejected only for age at diagnosis (D = 0.078, p < 0.01). The populations therefore, were drawn from different distributions, as there are more patients with relapsing disease in the clinical cohort. In all other analyses performed, the populations were shown to be drawn from the same distribution.
      Our analysis has shown that the UKMSR portal population is highly analogous to the entirely clinical (validated) population. This supports the validity of the self-reported diagnosis and therefore that the portal population can be utilised as a viable and valid cohort of people with Multiple Sclerosis for study.

      Graphical abstract


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Multiple Sclerosis and Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Brownlee WJ
        • Hardy TA
        • Fazekas F
        • Miller DH
        Diagnosis of multiple sclerosis: progress and challenges.
        Lancet. 2017; 389: 1336-1346
        • Leray E
        • Yaouanq J
        • Le Page E CoustansM
        • Laplaud D
        • Oger J
        • et al.
        Evidence for a two-stage disability progression in multiple sclerosis.
        Brain. 2010; 133: 1900-1913
        • Thompson AJ.
        Challenge of progressive multiple sclerosis therapy.
        Curr. Opin. Neurol. 2017; 30: 237-240
        • Ford DV
        • Jones KH
        • Verplancke J-P
        • Lyons RA
        • John G
        • Brown G
        • et al.
        The SAIL Databank: building a national architecture for e-health research and evaluation.
        BMC Health Serv. Res. 2009; 9: 157
        • Flachenecker P
        • Stuke K
        National MS registries.
        J. Neurol. 2008; 255: 102-108
        • Sayers A
        • Ben-Shlomo Y
        • Blom AW
        • Steele F
        Probabilistic record linkage.
        Int. J. Epidemiol. 2016; 45: 954-964
        • Health and Social Care Information Centre
        NHS ICD-10 5th Edition XML data files releases [Internet].
        Date: 2015
        (NHS Classifications ICD10 5th Edition[cited 2016 Nov 10]. Available from
        • NHS Digital
        UK Read Code [Internet]. UK Read Code.
        Date: 2016
        ([citedNov 10]. Available from:
        • Marrie RA
        • Cutter G
        • Tyry T
        • Campagnolo D
        • Vollmer T
        Validation of the NARCOMS registry: diagnosis.
        Mult. Scler. 2007; 13 (February 9): 770-775
        • UK MS Register
        UK MS Regsiter Terms and Conditions [Internet]. UK MS Register, terms and conditions.
        Date: 2012
        ([cited 2016 Nov 16]. Available from
        • Zigmond A
        • Snaith R.P.
        The hospital anxiety and depression scale.
        Acta Psychiatr Scaninavica. 1983; 67: 361-370
        • Brooks R.
        EuroQol: the current state of play.
        Health Policy. 1996; 37: 53-72
        • Hobart J
        The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure.
        Brain. 2001; 124 (May 1): 962-973
        • Polman CH
        • Reingold SC
        • Banwell B
        • Clanet M
        • Cohen JA
        • Filippi M
        • et al.
        Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria.
        Ann. Neurol. 2011; 69: 292-302
        • R Development Team
        R: a language and environment for statistical computing [Internet].
        Date: 2011
        (Available from
        • Ford DV
        • Jones KH
        • Middleton RM
        • Lockhart-Jones H
        • Maramba ID
        • Noble GJ
        • et al.
        The feasibility of collecting information from people with Multiple Sclerosis for the UK MS Register via a web portal: characterising a cohort of people with MS.
        BMC Med. Inform. Decis. Mak. 2012; 12: 73
        • ONS
        Population Estimates for UK, England and Wales.
        Scotland and Northern Ireland, 2015 (mid[Internet]. Statistical Bulletin. Available from)
        • Boiko A
        • Vorobeychik G
        • Paty D
        • Devonshire V
        • Sadovnick D
        the UBC MS clinic neurologists. Early onset multiple sclerosis: a longitudinal study.
        Neurology. 2002; 59 (October 8): 1006-1010
        • Sumelahti M-L
        • Holmberg MHA
        • Murtonen A
        • Huhtala H
        • Elovaara I
        Increasing incidence in relapsing-remitting ms and high rates among young women in finland: a thirty-year follow-up.
        Mult. Scler. Int. 2014; 2014: 1-8
        • MSIF
        Atlas of MS [Internet].
        Atlas MS. 2013; ([cited 2016 Nov 7]. Available from)
        • Harding KE
        • Wardle M
        • Moore P
        • Tomassini V
        • Pickersgill T
        • Ben-Shlomo Y
        • et al.
        Modelling the natural history of primary progressive multiple sclerosis.
        J. Neurol. Neurosurg. Psychiatry. 2015; 86: 13-19
        • Miller DH
        • Leary SM
        Primary-progressive multiple sclerosis.
        Lancet Neurol. 2007; 6: 903-912
        • Ribbons KA
        • McElduff P
        • Boz C
        • Trojano M
        • Izquierdo G
        • Duquette P
        • et al.
        Male sex is independently associated with faster disability accumulation in relapse-onset ms but not in primary progressive MS.
        PLoS One. 2015; 10 (Aktas O, editor) (June 5)e0122686
        • Paulus A
        • Hussack S
        • Kugler J
        Multiple Sklerose – Ergebnisse einer Befragung der Mitglieder des DMSG-Landesverbandes e.V. in Sachsen-Anhalt: Durch welche Faktoren wird die Diagnosedauer beeinflusst?.
        Fortschritte Neurol • Psychiatr. 2016; 84 (August 29): 487-493
        • Mackenzie IS
        • Morant SV
        • Bloomfield GA
        • MacDonald TM
        • O'Riordan J
        Incidence and prevalence of multiple sclerosis in the UK 1990-2010: a descriptive study in the General Practice Research Database.
        J. Neurol. Neurosurg. Psychiatry. 2014; 85 (January 1): 76-84
        • Prescott Cecil
        Internet users in the UK: 2016 [Internet].
        Stat. Bull. 2016; ([cited 2017 Apr 26]. Available from)
        • Fox S
        • Purcell Kristen
        Chronic disease and the internet [Internet].
        Pew. Res. Center. 2010; ([cited 2016 Nov 9]. Available from)
        • Waterson P.
        Health information technology and sociotechnical systems: a progress report on recent developments within the UK National Health Service (NHS).
        Appl. Ergon. 2014; 45: 150-161
        • Kremenchutzky M.
        The natural history of multiple sclerosis: a geographically based study 9: Observations on the progressive phase of the disease.
        Brain. 2006; 129 (January 6): 584-594
        • Leray E
        • Moreau T
        • Fromont A
        • Edan G
        Epidemiology of multiple sclerosis.
        Rev. Neurol. (Paris). 2016; 172: 3-13
        • Motl RW
        • Pilutti LA
        • Learmonth YC
        • Goldman MD
        • Brown T
        Clinical Importance of steps taken per day among persons with multiple sclerosis.
        PLoS One. 2013; 8 (Villoslada P, editor) (September 4): e73247